|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,783.20 INR | -1.08% |
|
-1.45% | +30.69% |
| Market Cap | 338B 3.51B 3.07B 2.83B 2.61B 4.92B 5.03B 33.87B 13.31B 166B 13.19B 12.9B 570B | P/E 2026 |
32.7x | P/E 2027 * | 29.3x |
|---|---|---|---|---|---|
| Enterprise Value | 345B 3.58B 3.13B 2.89B 2.66B 5.02B 5.13B 34.55B 13.57B 169B 13.45B 13.15B 582B | EV / Sales 2026 |
3.33x | EV / Sales 2027 * | 3.28x |
| Free-Float |
18.3% | Yield 2026 |
0.23% | Yield 2027 * | 0.21% |
Last Transcript: Emcure Pharmaceuticals Limited
| 1 day | -1.08% | ||
| 1 week | -1.45% | ||
| Current month | -2.88% | ||
| 1 month | +2.78% | ||
| 3 months | +8.80% | ||
| 6 months | +14.42% | ||
| Current year | +30.69% |
| 1 week | 1,751 | 1,840 | |
| 1 month | 1,725.7 | 1,944 | |
| Current year | 1,381 | 1,944 | |
| 1 year | 1,260 | 1,944 | |
| 3 years | 889 | 1,944 | |
| 5 years | 889 | 1,944 | |
| 10 years | 889 | 1,944 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 15/04/1981 | |
| Director of Finance/CFO | - | 30/09/2003 | |
| Compliance Officer | - | 03/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | - | |
| Director/Board Member | 72 | 22/07/2001 | |
| Director/Board Member | 75 | 15/04/1981 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.08% | -1.45% | +30.88% | - | 3.55B | ||
| +0.85% | -3.11% | +49.29% | +162.34% | 1,043B | ||
| +1.23% | -2.34% | +53.56% | +58.28% | 602B | ||
| +0.04% | +1.83% | +33.53% | +87.11% | 449B | ||
| +0.78% | -0.39% | +30.44% | +23.23% | 327B | ||
| +1.41% | +0.56% | +31.41% | +47.13% | 279B | ||
| -0.27% | -5.69% | +20.68% | +21.99% | 264B | ||
| -1.42% | +0.73% | +22.50% | +61.06% | 201B | ||
| -1.48% | -0.42% | +22.24% | +73.96% | 169B | ||
| -0.36% | +3.30% | +1.79% | -31.03% | 143B | ||
| Average | -0.08% | -0.67% | +29.63% | +56.01% | 348.06B | |
| Weighted average by Cap. | +0.15% | -1.81% | +37.79% | +83.50% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 91.56B 951M 831M 767M 707M 1.33B 1.36B 9.17B 3.6B 44.83B 3.57B 3.49B 154B | 104B 1.08B 948M 875M 806M 1.52B 1.55B 10.46B 4.11B 51.12B 4.07B 3.98B 176B |
| Net income | 9.81B 102M 89.07M 82.23M 75.76M 143M 146M 983M 386M 4.8B 383M 374M 16.55B | 11.5B 119M 104M 96.36M 88.77M 167M 171M 1.15B 452M 5.63B 448M 439M 19.4B |
| Net Debt | 6.75B 70.1M 61.28M 56.57M 52.12M 98.27M 100M 676M 266M 3.3B 263M 257M 11.39B | 4.56B 47.41M 41.44M 38.26M 35.25M 66.46M 67.93M 457M 180M 2.23B 178M 174M 7.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | ₹1,783.20 | -1.08% | 239,836 |
| 16/07/26 | ₹1,802.70 | +0.69% | 120,724 |
| 15/07/26 | ₹1,790.30 | -1.09% | 95,679 |
| 14/07/26 | ₹1,810.10 | +0.94% | 138,088 |
| 13/07/26 | ₹1,793.30 | -1.16% | 87,267 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EMCURE Stock
Select your edition
All financial news and data tailored to specific country editions


















